European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.
Asianet Newsable on MSN
Hepatitis B & C: Preventable liver diseases still killing millions worldwide
From a clinical perspective, these are conditions in which outcomes can change significantly. But that depends on when we ...
US FDA grants accelerated approval to Gilead’s Hepcludex for the treatment of chronic hepatitis delta virus: Foster City, California Tuesday, May 26, 2026, 10:00 Hrs [IST] Gilea ...
SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, compares potenti ...
In conjunction with World Hepatitis Day, observed annually on July 28, the Ministry of Health announced significant progress ...
In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe. Her supervisor, a fellow Dane named Peter Aaby, had spent nearly two decades collecting data ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in adults with relapsing forms of multiple sclerosis (RMS) at ...
WPS in recent drug trafficking arrest in Winnipeg. Sofia Frolova reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results